Cheol-In Kang

Cheol-In Kang

Auto-generated profile, based on publicly available information

Cheol-In Kang

Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Infection & Chemotherapy
Verified
Journal Article
Open access
PDF file
CKCheol-In Kang
Cheol-In Kang
JKJieun Kim
Jieun Kim
DPDae Won Park
Dae Won Park
BKBaek-Nam Kim
Baek-Nam Kim
UHU-Syn Ha
U-Syn Ha
SWSeong-Heon Wie
Seong-Heon Wie
Kang CI, et al. Infect Chemother. 2018 Mar;50(1):67-100. https://doi.org/10.3947/ic.2018.50.1.67

1 January 2013 in Infection & Chemotherapy
Verified
Journal Article
Open access
PDF file
CKCheol-In Kang
Cheol-In Kang
JSJae-Hoon Song
Jae-Hoon Song
Kang CI, et al. Infect Chemother. 2013 Mar;45(1):22-31. http://dx.doi.org/10.3947/ic.2013.45.1.22

1 January 2006 in Journal of Korean Medical Science
Verified
Journal Article
Open access
CKCheol In Kang
Cheol In Kang
SKSung Han Kim
Sung Han Kim
JBJi Whan Bang
Ji Whan Bang
HKHong Bin Kim
Hong Bin Kim
NKNam Joong Kim
Nam Joong Kim
KCKang Won Choe
Kang Won Choe
We conducted this study to compare clinical features, outcomes, and clinical implication of antimicrobial resistance in Klebsiella pneumoniae bacteremia acquired as community vs. nosocomial infection. A total of 377 patients with K. pneumoniae bacteremia (191 community-acquired and 186 nosocomial) were retrospectively analyzed. Neoplastic diseases (hematologic malignancy and solid tumor, 56%) were the most commonly associated conditions in patients with nosocomial bacteremia, whereas chronic liver disease (35%) and diabetes mellitus (20%) were the most commonly associated conditions in patients with community-acquired bacteremia. Bacteremic liver abscess occurred almost exclusively in patients with community-acquired infection. The overall 30-day mortality was 24% (91/377), and the mortality of nosocomial bacteremia was significantly higher than that of community-acquired bacteremia (32% vs. 16%, p<0.001). Of all community-acquired and nosocomial isolates, 4% and 33%, respectively, were extended-spectrum cephalosporin (ESC)-resistant, and 4% and 21%, respectively, were ciprofloxacin (CIP)-resistant. In nosocomial infections, prior uses of ESC and CIP were found to be independent risk factors for ESC and CIP resistance, respectively. Significant differences were identified between community-acquired and nosocomial K. pneumoniae bacteremia, and the mortality of nosocomial infections was more than twice than that of community-acquired infections. Antimicrobial resistance was a widespread nosocomial problem and also identified in community-acquired infections.

1 January 2016 in Infection & Chemotherapy
Verified
Journal Article
Open access
PDF file
WCWon Suk Choi
Won Suk Choi
CKCheol-In Kang
Cheol-In Kang
YKYonjae Kim
Yonjae Kim
JCJae-Phil Choi
Jae-Phil Choi
JJJoon Sung Joh
Joon Sung Joh
TDThe Korean Society Of Infectious Diseases
The Korean Society Of Infectious Diseases
Choi WS, et al. Infect Chemother. 2016 Jun;48(2):118-126. https://doi.org/10.3947/ic.2016.48.2.118

1 January 2014 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
SCSun Young Cho
Sun Young Cho
CKCheol-In Kang
Cheol-In Kang
JKJungok Kim
Jungok Kim
YHYoung Eun Ha
Young Eun Ha
DCDoo Ryeon Chung
Doo Ryeon Chung
JSJae-Hoon Song
Jae-Hoon Song
A retrospective study was conducted to evaluate the efficacy of levofloxacin in the treatment of Stenotrophomonas maltophilia bacteremia. The 30-day mortality rates were similar between the trimerthoprim-sulfamethoxazole (TMP-SMX) and levofloxacin treatment groups. Adverse events related to antibiotics occurred more frequently in patients receiving TMP-SMX, and recurrent bacteremia due to levofloxacin-resistant S. maltophilia strains developed in patients treated with levofloxacin. Our data suggest that levofloxacin can be a useful alternative option for treating S. maltophilia infections.

1 February 2012 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
PDF file
CKCheol-In Kang
Cheol-In Kang
YWYu Mi Wi
Yu Mi Wi
MLMi Young Lee
Mi Young Lee
Kwan Soo KoKwan Soo Ko
Kwan Soo Ko
DCDoo Ryeon Chung
Doo Ryeon Chung
JSJae-Hoon Song
Jae-Hoon Song
Limited clinical information is available regarding community onset infections caused by extended-spectrum β-lactamase (ESBL)-producing Escherichia coli . A case-control study was performed to evaluate the epidemiology and risk factors of these types of infections. A case patient was defined as a person whose clinical sample yielded ESBL-producing E. coli . For each case patient, one control was randomly chosen from a group of outpatients from whom non-ESBL-producing E. coli had been isolated and for whom a clinical sample had been sent to the same laboratory for culturing during the following week. Of 108 cases of ESBL-producing E. coli , 56 (51.9%) were classified as health care associated (HCA). Univariate analysis showed male gender, HCA infection, severe underlying illness, and a prior receipt of antibiotics to be associated with ESBL-producing E. coli . In the multivariate analysis, HCA infection (odds ratio [OR], 3.18; 95% confidence interval [CI], 1.67 to 6.06; P < 0.001) and previous use of antibiotics (OR, 4.88; 95% CI, 2.08 to 11.48; P < 0.001) were found to be significantly associated with the ESBL group. In a multivariate analysis that included each antibiotic, previous use of fluoroquinolone (OR, 7.32; 95% CI, 1.58 to 34.01; P = 0.011) was significantly associated with ESBL-producing E. coli . Of 101 isolates in which ESBLs and their molecular relationships were studied, all isolates produced ESBLs from the CTX-M family (CTX-M-14, 40 isolates; CTX-M-15, 39 isolates; and other members of the CTX-M family, 22 isolates). In conclusion, this study confirms that ESBL-producing E. coli strains are a notable cause of community onset infections in predisposed patients. HCA infection and previous use of fluoroquinolone were significant factors associated with ESBL-producing E. coli in community onset infections.